Literature DB >> 8691486

Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial cancer cell growth.

R K Erukulla1, X Zhou, P Samadder, G Arthur, R Bittman.   

Abstract

Two ether glucosyl diglyceride analogs were synthesized, and their antiproliferative activity against four epithelial cancer cell lines was evaluated. 1-O-Hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol (4) was synthesized by reaction of 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-glucopyranosyl chloride with 1-O-hexadecyl-2-O-methyl-sn-glycerol followed by deacetylation by methanolic hydrolysis. The N-acetyl group of 4 was removed by hydrolysis with ethanolic potassium hydroxide to form 1-O-hexadecyl-2-O-methyl-3-O-(2'-amino-2'-deoxy-beta-D-glucopyranosyl)- sn-glycerol (5). Compounds 4 and 5 inhibited the proliferation of MCF-7, A549, A427, and T84 cancer cell lines. The IC(50) values for 5 ranged from 6.5 to 12.2 microM, whereas 4 was more effective against A549 cells (IC(50) 9 microM) than against MCF-7 (IC(50) 17 microM) and A427 (IC(50) 25 microM) cells and was inactive against T84 cells. Under identical incubation conditions, compounds 4 and 5 were potent inhibitors of the proliferation of OVCAR-3 cells with IC(50) values of 12 and 4 microM, respectively, whereas ET-18-OCH(3), hexadecylphosphocholine, and erucylphosphocholine had IC(50) values of 24, >30, and >30 microM, respectively. The cell-inhibitory profile of these ether-linked glucosyl diglycerides strengthens the hypothesis that such glycolipids represent a distinct group of antitumor ether lipids, having antineoplastic activities that differ from the well-known alkylphosphocholines and alkyllysophospholipids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691486     DOI: 10.1021/jm950928f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.

Authors:  Amani I Moraya; Jennifer L Ali; Pranati Samadder; Lisa Liang; Ludivine Coudière Morrison; Tamra E Werbowetski-Ogilvie; Makanjuola Ogunsina; Frank Schweizer; Gilbert Arthur; Mark W Nachtigal
Journal:  J Exp Clin Cancer Res       Date:  2017-05-12

2.  Structure activity relationships of N-linked and diglycosylated glucosamine-based antitumor glycerolipids.

Authors:  Makanjuola Ogunsina; Hangyi Pan; Pranati Samadder; Gilbert Arthur; Frank Schweizer
Journal:  Molecules       Date:  2013-12-10       Impact factor: 4.411

Review 3.  The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer.

Authors:  Mark W Nachtigal; Alon D Altman; Rajat Arora; Frank Schweizer; Gilbert Arthur
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.